Pantoprazole treatment increased lysosome abundance in AGS cells compared with control cells. In a recombinant TOPK binding assay, Pantoprazole exhibited the lowest equilibrium dissociation constant. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Pantoprazole and lysosome abundance in AGS cells
Cell-based study · AGS cells [1]
AGS cells received Pantoprazole at 120 μg/ml for 48 h under pH 7.4 conditions. Lysosome abundance increased compared with control cells.
Literature-Reported Treatment Conditions
- Treatment concentration
- 120 μg/ml
- Exposure duration
- 48 h in pH 7.4 condition
- Vehicle
- complete medium (CM)
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Pantoprazole
Evidence for Pantoprazole as the sodium form reported in the paper, not the free base/neutral form supplied as A11696; no salt equivalence, dose conversion or lot validation.
Results > PPI-induced autophagosome formation via TM9SF4-mTOR pathway (S13, S14); Materials and methods > Cell viability assay and quantitative methods for drug interaction analysis (S164)
abundance of lysosomes: abundance of lysosomes; comparator: control cells — Results > PPI-induced autophagosome formation via TM9SF4-mTOR pathway (S14)
Pantoprazole binding to recombinant TOPK
Biochemical assay · Recombinant TOPK [2]
Recombinant TOPK was incubated with serially diluted Pantoprazole for 10 minutes at room temperature. Pantoprazole exhibited the lowest equilibrium dissociation constant, with a Kd of 24.2± 2.32 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- 5mM pantoprazole as the highest concentration for the serial dilution
- Exposure duration
- 10 minutes incubation at room temperature
- Vehicle
- ddH2O
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Pantoprazole
Evidence for Pantoprazole as the sodium form reported in the paper, not the free base/neutral form supplied as A11696; no salt equivalence, dose conversion or lot validation.
RESULTS > Virtual ligand screening identifies the binding of pantoprazole to TOPK (S10, S12, S13); MATERIALS AND METHODS > Microscale thermophoresis (MST) (S59, S62, S63, S64)
binding affinity between the compounds and TOPK: binding affinity between the compounds and TOPK; comparator: HI-TOPK-032 — RESULTS > Virtual ligand screening identifies the binding of pantoprazole to TOPK (S10, S12)